CHIR99021 (WNT pathway activator; Inhibits GSK3), 10mg
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0473478
- Awardee
- StemCell Technologies Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $346.00
About this award
StemCell Technologies Inc was awarded a contract by the University of Virginia on August 26, 2026, valued at $346. The prime contractor will deliver CHIR99021, a Wnt pathway activator that inhibits glycogen synthase kinase 3 (GSK3), in a quantity of one unit at 10 milligrams. The product will be delivered to Stef Gunst at the University of Virginia located in Virginia.
This purchase order (PO-0473478) represents a straightforward procurement of specialized research materials. The contract amount of $346 reflects a single-unit purchase of a biochemical compound commonly utilized in stem cell research and differentiation protocols. No additional information regarding contract performance period, delivery timeline, or alternative line items is provided in the available documentation.
Line items
| Item | Total |
|---|---|
| CHIR99021 (WNT pathway activator; Inhibits GSK3), 10mg | $346.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0473478?
Contract A207_PO-0473478 was awarded to StemCell Technologies Inc by University of Virginia on August 26, 2026.
How much is contract A207_PO-0473478 worth?
Its cumulative value is $346.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award